Tuesday, 5 November 2019

Questions (442)

Alan Kelly

Question:

442. Deputy Alan Kelly asked the Minister for Health the volume of uptake of biosimilar prescribing under the best value biologic process by the HSE to date in 2019; the number of patients prescribed biosimilars by treatment type to date in 2019; the average savings per patient compared to the originator drugs; and if he will make a statement on the matter. [44252/19]

View answer

Written answers (Question to Health)

As this is an operational matter it has been referred to the Health Service Executive for direct reply to the Deputy.